Emergent Biosolutions - Stock Price History | EBS
Historical daily share price chart and data for Emergent Biosolutions since 2023 adjusted for splits. The latest closing stock price for Emergent Biosolutions as of March 27, 2023 is 8.86.
- The all-time high Emergent Biosolutions stock closing price was 134.94 on August 13, 2020.
- The Emergent Biosolutions 52-week high stock price is 44.04, which is 397.1% above the current share price.
- The Emergent Biosolutions 52-week low stock price is 7.74, which is 12.6% below the current share price.
- The average Emergent Biosolutions stock price for the last 52 weeks is 22.76.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Emergent Biosolutions Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2022 |
30.3077 |
47.9700 |
52.2200 |
11.0000 |
11.8100 |
-72.83% |
| 2021 |
67.7216 |
93.1000 |
125.1900 |
33.1100 |
43.4700 |
-51.48% |
| 2020 |
83.1653 |
54.0000 |
134.9400 |
49.3400 |
89.6000 |
66.08% |
| 2019 |
51.8647 |
57.7000 |
66.1600 |
39.9200 |
53.9500 |
-8.99% |
| 2018 |
56.2235 |
47.9700 |
73.2400 |
44.4400 |
59.2800 |
27.57% |
| 2017 |
34.9138 |
33.2300 |
47.7500 |
28.3000 |
46.4700 |
41.50% |
| 2016 |
32.0599 |
35.6916 |
41.4356 |
24.6000 |
32.8400 |
-12.40% |
| 2015 |
29.9068 |
25.2062 |
37.7437 |
24.5784 |
37.4907 |
46.93% |
| 2014 |
22.3056 |
22.5075 |
26.3212 |
18.6657 |
25.5154 |
18.44% |
| 2013 |
16.1497 |
15.8358 |
22.4419 |
12.2564 |
21.5424 |
43.33% |
| 2012 |
14.1415 |
15.9295 |
17.1852 |
12.0971 |
15.0300 |
-4.75% |
| 2011 |
19.1232 |
22.2826 |
23.4071 |
14.0742 |
15.7796 |
-28.22% |
| 2010 |
15.9711 |
12.9404 |
22.3014 |
12.6125 |
21.9828 |
72.63% |
| 2009 |
14.8789 |
23.5101 |
24.6065 |
9.0142 |
12.7343 |
-47.95% |
| 2008 |
11.5790 |
4.7695 |
24.4659 |
4.6758 |
24.4659 |
416.01% |
| 2007 |
9.7116 |
10.5885 |
15.9108 |
4.4134 |
4.7414 |
-54.66% |
| 2006 |
10.1429 |
10.9633 |
10.9633 |
9.1548 |
10.4573 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.406B |
$1.121B |
|
Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. It also supplies vaccines to domestic and international non-government organizations and governments in/ outside of the U.S. BioThrax is the company's key Biodefense product, used for anthrax disease. The U.S. government is the primary purchaser of the company's Biodefense products. It supplies adjuvanted anthrax vaccine candidate, AV7909, to the U.S. government. It supplies smallpox vaccine ACAM2000, botulism therapeutic BAT, anthrax therapeutics 'raxibacumab & Anthrasil' and 3 other products to governments of different countries. It also retails 3 products Narcan nasal spray, Vaxchora and Vivoti. It provides contract development and manufacturing services to multiple pharma and biotech companies. The company has added key products Narcan nasal spray, ACAM2000, raxibacumab, Vaxchora and Vivoti through several acquisitions.
|
